Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06395025
Other study ID # P001D23
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 17, 2023
Est. completion date February 29, 2024

Study information

Verified date April 2024
Source Millet Innovation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary goal of this study is to assess in vivo the efficacy of the insoles, in improving venous return in subjects affected by this problem after 14 days of the initial measurements, by self-assessment, filling-in questions regarding Quality of Life, in comparison with a control group. The secondary goal of this study is to assess in vivo the acceptability of the subjects regarding the same medical device, after 14 days of using the medical device, by selfassessment, filling-in subjective evaluation questions.


Recruitment information / eligibility

Status Completed
Enrollment 110
Est. completion date February 29, 2024
Est. primary completion date February 29, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Gender: Female/Male; - Age: with 18 years old and older; - Having signed an Informed Consent Form (ICF); - Willingness, ability and likeliness to comply with all the study procedures and restrictions; - Ability to give informed consent; - Available during the entire study period; - Understanding Portuguese language: Portuguese-speaking subjects capable of reading the documents; - Affected by a symptomatic venous return problem; - With a score >14 from the question 1 to 11 of the adapted CIVIQ questionnaire; - With shoes suitable for insoles (with heel <2.5cm); - Having a size of 36 to 44; - Is taking a venotonic as a regular therapy with a daily dosage; Exclusion Criteria: - Known allergy or known history of hypersensitivity to the components of the investigational device and related compounds; - Currently participating in another clinical study that may interfere with the study; - Diagnosed skin diseases and/or cutaneous alterations on the test region (under the feet) that may impair the study (for example tattoos, marks, burns, scars, etc.); - Diagnosed diseases that may impair the study (including but not limited to: Diabetes, Arteritis, Phlebitis, etc); - Under pharmacological treatments on the 30 days previous to the beginning of the study and during the entire period of the study that may impair it (including but not limited to: inflammatory drugs, any drug that might cover the signs and symptoms, drugs with arterial or venous indications, etc.); - Having applied any type of topical product (pharmaceutical, cosmetic or other) with similar effect of the medical device under study, on the test region (feet) during the study, besides the investigational device; - Having a stage of CVD C3 on the CEAP classification; - Having had a traumatic or neurological history in the last 6 months; - Wearing an orthopaedic insole made by a health professional; - Having a significant and disabling lower limb pain; - Having a significant and disabling back pain; - Having a contraindication to wearing insoles; - Pregnancy or intention to conceive during the study; - Breast-feeding.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Insoles
Insoles At Day 0, the patient received the insoles and adapted them to his shoes. The patient filled the quality-of-life's questionnaire at Day 0 and the same at Day14. The patient filled a usability's questionnaire at Day14.

Locations

Country Name City State
Portugal Inovapotek Porto

Sponsors (1)

Lead Sponsor Collaborator
Millet Innovation

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of Life Quality of Life evaluation before (t0) and after 14 days (t14) of using the medical device Therapeutic insoles LIGHT LEGS, to assess the quality-of-life improvement subjects; Day 0 and Day 14
Secondary Usability evaluation Usability of the subjects regarding the same device, through subjective evaluation questions filled by the subjects after 14 days (t14) of using the medical device Day 14
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT06238557 - Prospective Evaluation of Psychological Consequences and Impact on Long-term Quality of Life
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT05472935 - Asynchronous Mindfulness Based Stress Reduction to Reduce Burnout in Licensed Clinical Social Workers N/A
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Active, not recruiting NCT04746664 - Effects of Nutrition Counselling on Old Age People's Nutritional Status and Quality of Life in Bahir Dar City, North West Ethiopia N/A
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Recruiting NCT04142827 - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) N/A
Active, not recruiting NCT05903638 - A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT03813420 - Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level N/A
Recruiting NCT05550545 - Infant RSV Infections and Health-related Quality of Life of Families
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Recruiting NCT05233020 - Robotic Versus Hybrid Assisted Ventral Hernia Repair N/A
Terminated NCT03304184 - The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life Phase 3
Completed NCT05063305 - Probiotics, Immunity, Stress, and QofL N/A
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A